{"public_id":"co_c559ae82d6ad4bc512f2253e6a8a49a5","status":"active","merged_into_public_id":null,"resolved_public_id":"co_c559ae82d6ad4bc512f2253e6a8a49a5","name":"drug development strategies","description":"Approaches for designing and improving therapeutic agents.","aliases":[],"types":["strategy"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":583709,"title":"Interferons at age 50: past, current and future impact on biomedicine","citation_count":1171,"url":"https://sah.borca.ai/papers/583709"}],"claims":[{"public_id":"cl_f4d1f31e016497c069aeac0e2ad2363b","text":"Elucidation of interferon-induced genes and drug development strategies targeting interferon production via Toll-like receptor activation are expected to lead to newer and more efficacious therapeutics.","corpus_id":583709,"url":"https://sah.borca.ai/claims/cl_f4d1f31e016497c069aeac0e2ad2363b"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_c559ae82d6ad4bc512f2253e6a8a49a5","url":"https://sah.borca.ai/concepts/co_c559ae82d6ad4bc512f2253e6a8a49a5"}